This is the first report with a higher prescription rate for AOM tirzepatide (sold as Zepbound) compared to AOM semaglutide (sold as Wegovy)
Il primo componente, la semaglutide, un agonista del recettore GLP-1 (glucagon-like peptide-1) gi noto e utilizzato con successo nel trattamento dellobesit e del diabete tipo 2
This article will provide a clear, easy-to-understand guide to help people make informed decisions about using these medications for effective weight management
Tirzepatide mimics two hormones, GIP and GLP-1, which signal the brain that you are full and slow the rate of gastric emptying, which refers to how quickly a meal leaves the stomach and enters the small intestine
Not only can this be mitigated with adequate nutrition and exercise, but we can titrate the dose of the medication more slowly, which can help to control the rate of weight loss and minimize side effects, she said
It was approved in the UK by the MHRA on 11 June 2026